Remove Biosimilars Remove Customer Service Related Topics
article thumbnail

Biocon buys Viatris biosimilars for $3.3bn, eyes IPO

pharmaphorum

India’s Biocon has expanded its pipeline of biosimilars with a $3.3 Biocon’s partnership with Mylan – which merged with Pfizer’s Upjohn to form Viatris in 2020 – dates back more than a decade and has generated a number of biosimilars including insulin analogues, antibodies and recombinant proteins.

article thumbnail

Do You Hear What I Hear? One Year of OTC Hearing Aids

FDA Law Blog: Biosimilars

According to HIA, OTC buyers receiving some assistance from a hearing care professional or from customer service representations may have higher rates of satisfaction and lower returns to the company than those buyers who receive no assistance at all, suggesting that a hybrid OTC model is working for some customers.